Medicxi

Medicxi is a European life sciences investment firm founded in 2016 and established by the former life sciences team of Index Ventures. It creates, invests in, and supports biotechnology companies across the drug development continuum, from early stages through growth, with a stated focus on novel therapies addressing unmet medical needs.

The firm invests in the United States and Europe and operates from three offices: London, which serves as headquarters, St. Helier in Jersey, and Geneva. Its activity spans life sciences investing, biotech company creation, drug development, and therapeutic innovation, positioning it across the healthcare and drug development continuum rather than at a single point in a company's lifecycle.

Medicxi's investment thesis is organised around unmet medical need, and the firm supports portfolio companies at differing stages of development. Industry verticals in which it operates include life sciences, biotechnology, pharmaceuticals and drug development, healthcare, and venture capital.